MA41812A - Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc - Google Patents
Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhcInfo
- Publication number
- MA41812A MA41812A MA041812A MA41812A MA41812A MA 41812 A MA41812 A MA 41812A MA 041812 A MA041812 A MA 041812A MA 41812 A MA41812 A MA 41812A MA 41812 A MA41812 A MA 41812A
- Authority
- MA
- Morocco
- Prior art keywords
- intermediaries
- hcv
- preparation
- methods
- protease inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/82—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/001—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by metabolizing one of the enantiomers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/61—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15161431 | 2015-03-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA41812A true MA41812A (fr) | 2018-01-30 |
Family
ID=52737010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA041812A MA41812A (fr) | 2015-03-27 | 2016-03-24 | Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20180093943A1 (fr) |
| EP (1) | EP3274324A1 (fr) |
| JP (1) | JP2018517661A (fr) |
| KR (1) | KR20170131449A (fr) |
| CN (1) | CN107429270A (fr) |
| AU (1) | AU2016241924A1 (fr) |
| BR (1) | BR112017019898A2 (fr) |
| CA (1) | CA2976175A1 (fr) |
| EA (1) | EA201792114A1 (fr) |
| HK (1) | HK1247246A1 (fr) |
| IL (1) | IL253899A0 (fr) |
| MA (1) | MA41812A (fr) |
| MX (1) | MX2017012348A (fr) |
| SG (1) | SG11201707594SA (fr) |
| WO (1) | WO2016157058A1 (fr) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2768B1 (en) * | 2005-07-29 | 2014-03-15 | تيبوتيك فارماسيوتيكالز ليمتد | Large cyclic inhibitors of hepatitis C virus |
| PE20070211A1 (es) | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
| AR065137A1 (es) | 2007-02-01 | 2009-05-20 | Tibotec Pharm Ltd | Procesos e intermediarios para la preparacion de un inhibidor de proteasa macrociclico del vhc y metodos de obtencion de los mencionados intermediarios. |
| EA201071034A1 (ru) | 2008-04-15 | 2011-06-30 | Интермьюн, Инк. | Новые макроциклические ингибиторы репликаций вируса гепатита с |
| SI2382198T1 (sl) | 2008-12-23 | 2013-11-29 | Janssen Pharmaceuticals, Inc. | Postopek in vmesne spojine za pripravo makrocikličnega inhibitorja HCV proteaze |
| AU2011229164B2 (en) | 2010-03-16 | 2015-11-26 | Janssen Pharmaceuticals, Inc. | Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV |
| WO2013028953A1 (fr) * | 2011-08-24 | 2013-02-28 | Glaxosmithkline Llc | Traitements combinés contre l'hépatite c |
| CN107011339A (zh) | 2011-09-22 | 2017-08-04 | 杨森制药公司 | 用于制备hcv的大环蛋白酶抑制剂的方法和中间体 |
| CA2848377A1 (fr) | 2011-10-28 | 2013-05-02 | Janssen Pharmaceuticals, Inc. | Procede ameliore pour la preparation d'un intermediaire de tmc 435 inhibiteur macrocyclique de protease |
-
2016
- 2016-03-24 MA MA041812A patent/MA41812A/fr unknown
- 2016-03-25 HK HK18106372.5A patent/HK1247246A1/zh unknown
- 2016-03-25 SG SG11201707594SA patent/SG11201707594SA/en unknown
- 2016-03-25 JP JP2017550186A patent/JP2018517661A/ja active Pending
- 2016-03-25 CA CA2976175A patent/CA2976175A1/fr not_active Abandoned
- 2016-03-25 EP EP16715347.7A patent/EP3274324A1/fr not_active Withdrawn
- 2016-03-25 WO PCT/IB2016/051720 patent/WO2016157058A1/fr not_active Ceased
- 2016-03-25 AU AU2016241924A patent/AU2016241924A1/en not_active Abandoned
- 2016-03-25 CN CN201680018539.7A patent/CN107429270A/zh active Pending
- 2016-03-25 KR KR1020177026974A patent/KR20170131449A/ko not_active Withdrawn
- 2016-03-25 EA EA201792114A patent/EA201792114A1/ru unknown
- 2016-03-25 US US15/559,910 patent/US20180093943A1/en not_active Abandoned
- 2016-03-25 BR BR112017019898A patent/BR112017019898A2/pt not_active Application Discontinuation
- 2016-03-25 MX MX2017012348A patent/MX2017012348A/es unknown
-
2017
- 2017-08-08 IL IL253899A patent/IL253899A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201792114A1 (ru) | 2018-01-31 |
| IL253899A0 (en) | 2017-10-31 |
| HK1247246A1 (zh) | 2018-09-21 |
| WO2016157058A1 (fr) | 2016-10-06 |
| CA2976175A1 (fr) | 2016-10-06 |
| MX2017012348A (es) | 2017-12-14 |
| JP2018517661A (ja) | 2018-07-05 |
| AU2016241924A1 (en) | 2017-08-24 |
| CN107429270A (zh) | 2017-12-01 |
| SG11201707594SA (en) | 2017-10-30 |
| EP3274324A1 (fr) | 2018-01-31 |
| US20180093943A1 (en) | 2018-04-05 |
| BR112017019898A2 (pt) | 2018-06-12 |
| KR20170131449A (ko) | 2017-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3507379A4 (fr) | Procédés d'amplification numérique du génome entier | |
| MA44884A (fr) | Dispositifs et procédés de thrombectomie de l'artère carotide interne | |
| EP3706784A4 (fr) | Compositions et procédés de production de lymphocytes t | |
| EP3590942A4 (fr) | Inhibiteur d'antigène de surface du virus de l'hépatite b | |
| MA50636A (fr) | Compositions et procédés pour inhiber l'activité d'arginase | |
| MA43365A (fr) | Anticorps anti-dr5 et procédés d'utilisation de ceux-ci | |
| EP3432926A4 (fr) | Procédés de réduction de la toxicité d'un médicament chimiothérapeutique | |
| EP3352774A4 (fr) | Compositions de flavonoïdes et procédés d'utilisation | |
| EP3359693A4 (fr) | Procédés et compositions pour enrichissement de produits d'amplification | |
| MA46315A (fr) | Polythérapies pour malignités hématologiques avec des anticorps anti-cd38 et des inhibiteurs de la survivine | |
| MA45688A (fr) | Compositions et procédés de potentialisation d'agents antimicrobiens | |
| IL253999A0 (en) | History of tetrahydrothiazepine in cyclics used to treat neoplastic and/or infectious diseases | |
| EP2791342A4 (fr) | Microorganismes modifiés et procédés de fabrication du butadiène à l'aide de ceux-ci | |
| EP3504196A4 (fr) | Procédés de préparation d'olaparib | |
| EP3472319A4 (fr) | Procédés de conception d'un génome sur la base de règles | |
| EP3289064A4 (fr) | Compositions et procédés pour la détection d'allergènes | |
| MA53445A (fr) | Procédés et compositions pour la modification de plantes | |
| EP3319653A4 (fr) | Procédés de préparation d'hydrogels et d'échafaudages ecm provenant du côlon | |
| EP3328429A4 (fr) | Peptides et anticorps pour l'élimination de biofilms | |
| EP3632914A4 (fr) | Inhibiteur d'antigène de surface du virus de l'hépatite b | |
| EP2967531A4 (fr) | Procédés et dispositifs pour la prévention des infections du site opératoire d'incision | |
| EP3488018A4 (fr) | Procédés et compositions pour l'identification de protéines | |
| EP3334522A4 (fr) | Adsorbants et procédés de fabrication et d'utilisation d'adsorbants | |
| EP3423091A4 (fr) | Compositions et procédés pour induire des anticorps du vih-1 | |
| EP3297954A4 (fr) | Sorbants pour l'élimination de mercure |